Bajaj Chemo-Plast (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-01-2025
- Paid Up Capital ₹ 1.00 M
as on 07-01-2025
- Company Age 45 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.10 Cr
as on 07-01-2025
- Revenue 23.24%
(FY 2023)
- Profit 8.69%
(FY 2023)
- Ebitda 5.14%
(FY 2023)
- Net Worth 15.72%
(FY 2023)
- Total Assets 20.22%
(FY 2023)
About Bajaj Chemo-Plast (India)
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.10 Cr.
Nilesh Laddhad, Sudhakar Kolarkar, and Nirmal Jejani serve as directors at the Company.
- CIN/LLPIN
U29299MH1979PLC022021
- Company No.
022021
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1979
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bajaj Chemo-Plast (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Laddhad  | Director | 03-Jun-2022 | Current |
| Sudhakar Kolarkar | Director | 01-Dec-2012 | Current |
| Nirmal Jejani | Director | 14-Aug-2003 | Current |
Financial Performance of Bajaj Chemo-Plast (India).
Bajaj Chemo-Plast (India) Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.24% increase. The company also saw a slight improvement in profitability, with a 8.69% increase in profit. The company's net worth Soared by an impressive increase of 15.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bajaj Chemo-Plast (India)?
In 2023, Bajaj Chemo-Plast (India) had a promoter holding of 82.40% and a public holding of 17.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gls Agricultures And Properties Private LimitedActive 21 years 5 months
Nirmal Jejani is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 12 Dec 1988 | ₹2.50 Cr | Open |
Indian Bank Creation Date: 12 Dec 1988 | ₹2.50 Cr | Open |
Indian Bank Creation Date: 26 Apr 1988 | ₹5.00 M | Open |
How Many Employees Work at Bajaj Chemo-Plast (India)?
Bajaj Chemo-Plast (India) has a workforce of 133 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bajaj Chemo-Plast (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bajaj Chemo-Plast (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
